verapamil has been researched along with Hypogonadism in 2 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Hypogonadism: Condition resulting from deficient gonadal functions, such as GAMETOGENESIS and the production of GONADAL STEROID HORMONES. It is characterized by delay in GROWTH, germ cell maturation, and development of secondary sex characteristics. Hypogonadism can be due to a deficiency of GONADOTROPINS (hypogonadotropic hypogonadism) or due to primary gonadal failure (hypergonadotropic hypogonadism).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ohebshalom, M | 1 |
| Mulhall, JP | 1 |
| De Marinis, L | 1 |
| Mancini, A | 1 |
| Minnielli, S | 1 |
| D'Amico, C | 1 |
| Di Pietro, ML | 1 |
| Albini, C | 1 |
| Passeri, M | 1 |
| Liberale, I | 1 |
| Menini, E | 1 |
| Barbarino, A | 1 |
1 review available for verapamil and Hypogonadism
| Article | Year |
|---|---|
Transdermal and topical pharmacotherapy for male sexual dysfunction.
Topics: Administration, Cutaneous; Administration, Topical; Alprostadil; Androgens; Animals; Erectile Dysfun | 2005 |
1 other study available for verapamil and Hypogonadism
| Article | Year |
|---|---|
Calcium antagonists and hormone release. V. Effects of a calcium-antagonist (verapamil) on pituitary hormone release in hypersecretory states.
Topics: Acromegaly; Adolescent; Adult; Cushing Syndrome; Female; Humans; Hypogonadism; Hypothyroidism; Male; | 1987 |